@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix m2: <https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M2_MetaConcepts.jsonld#> .
@prefix m3: <https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M3_GenesisSpace.jsonld#> .
@prefix ns1: <m0:> .
@prefix ns2: <m1:physio:> .
@prefix ns3: <m1:biology:> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<m0:blood_pressure_control:BloodPressureControl> a owl:NamedIndividual,
        <m1:core:Poclet> ;
    rdfs:label "Blood Pressure Homeostasis (5-Effector System)" ;
    rdfs:comment "Long-term regulation of arterial blood pressure through coordinated action of RAAS, Sympathetic NS, ADH, Natriuretic Peptides, and Cardiac Output. Set-point: ~120/80 mmHg in humans. Pathology: Chronic hypertension from dysregulation." ;
    ns1:asfid_analysis [ m3:A [ ] ;
            m3:D [ ] ;
            m3:F [ ] ;
            m3:I [ ] ;
            m3:S [ ] ] ;
    ns1:bicephalous_perspective [ ] ;
    ns1:effector_count 5 ;
    ns1:effectors <m0:blood_pressure_control:ADH>,
        <m0:blood_pressure_control:CardiacOutput>,
        <m0:blood_pressure_control:NatriureticPeptides>,
        <m0:blood_pressure_control:RAAS>,
        <m0:blood_pressure_control:Sympathetic> ;
    ns1:epistemic_gap [ ] ;
    ns1:future_extensions "Add endothelial regulation (NO, endothelin)",
        "Include genetic polymorphisms (renin, ACE, angiotensinogen genes)",
        "Link to chronic kidney disease (bidirectional causality)",
        "Model circadian variation (BP dipping at night)",
        "Separate poclets: Cardiac Output (Starling curve), RAAS Cascade, Baroreceptor Reflex" ;
    ns1:gamification_potential [ ] ;
    ns1:m1_concepts_used [ ns3:Endocrine "Circulating aldosterone, ADH, ANP" ;
            ns3:Paracrine "Local angiotensin II in kidneys and vessels" ;
            ns2:BaroreflexArc "PROPOSED - Baroreceptors → Vasomotor center → Sympathetic output" ;
            ns2:CardiacOutput "PROPOSED - CO = HR × SV" ;
            ns2:PressureNatriuresis "PROPOSED - Intrinsic renal pressure-dependent sodium excretion" ;
            ns2:RenalAutoregulation "PROPOSED - Myogenic + tubuloglomerular feedback" ] ;
    ns1:m2_metaconcepts_mobilized m2:Balance,
        m2:Bifurcation,
        m2:Cascade,
        m2:Dynamics,
        m2:Feedback,
        m2:Hierarchy,
        m2:Homeostasis,
        m2:Memory,
        m2:Network,
        m2:Regulation,
        m2:Threshold,
        m2:Trade-off ;
    ns1:orive_analysis [ m3:E [ ] ;
            m3:I [ ] ;
            m3:O [ ] ;
            m3:R [ ] ;
            m3:V [ ] ] ;
    ns1:phenomenon [ ] ;
    ns1:scientific_validation [ ] .

<m0:complex_chemical_synapse:BloodPressureControl> a owl:Ontology ;
    dcterms:created "2026-01-22" ;
    dcterms:creator "Echopraxium with the collaboration of Claude AI" ;
    dcterms:description "Poclet modeling long-term arterial blood pressure regulation through 5 physiological effector systems: RAAS, Sympathetic NS, ADH, Natriuretic Peptides, and Cardiac Output/Volemia. Demonstrates multi-scale homeostatic control (seconds to days)." ;
    dcterms:modified "2026-01-22" ;
    dcterms:title "Blood Pressure Control Poclet - TSCG M0 Layer" ;
    rdfs:comment "This poclet captures the coordinated action of 5 parallel regulatory systems maintaining arterial blood pressure homeostasis. It is the first physiological poclet in TSCG and demonstrates the highest effector count (5 vs 3-4 in other poclets). Validated against Guyton's quantitative model (1972) and clinical evidence from antihypertensive drug trials." ;
    rdfs:seeAlso "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/poclets/blood_pressure_control/M0_BloodPressureControl_README.md" ;
    owl:imports "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M1_CoreConcepts.jsonld",
        "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M1_extensions/M1_Biology.jsonld",
        "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M2_MetaConcepts.jsonld" ;
    owl:versionInfo "1.0.0" ;
    m2:ontologyCategory "Poclet" ;
    ns1:clinicalRelevance "Maximal (hypertension affects 30-40% of adults worldwide)" ;
    ns1:complexity "High (5 effectors, 3 timescales)" ;
    ns1:domain "Cardiovascular Physiology / Renal Physiology / Endocrinology" ;
    ns1:pocletType "Physiological Homeostasis" .

<m0:blood_pressure_control:ADH> a owl:NamedIndividual ;
    rdfs:label "Anti-Diuretic Hormone (ADH / Vasopressin)" ;
    rdfs:comment "Peptide hormone secreted by posterior pituitary. Primary role: water retention via V2 receptors in kidney collecting duct. Secondary role: vasoconstriction via V1 receptors in vascular smooth muscle." ;
    ns1:effector_type "Hormonal (peptide)" ;
    ns1:m2_metaconcepts "m2:Flow (F) - Regulates water flux across collecting duct",
        "m2:Regulation (A⊗S⊗F) - Osmotic/volumetric control",
        "m2:Signal (I⊗F) - Hormonal information carrier" ;
    ns1:mechanism "ADH circulates to kidneys",
        "Osmoreceptors (hypothalamus) sense ↑ osmolality → Stimulate ADH secretion",
        "V1 receptors (vascular smooth muscle) → Vasoconstriction → ↑ TPR → ↑ BP",
        "V2 receptors (collecting duct) → ↑ Aquaporin-2 expression → ↑ Water reabsorption",
        "↑ Water retention → ↑ Blood volume → ↑ BP" ;
    ns1:pathology "Excessive secretion (SIADH - syndrome of inappropriate ADH) causes hyponatremia" ;
    ns1:pharmacological_targets "V2 agonists (e.g., desmopressin) - treat diabetes insipidus",
        "V2 antagonists (e.g., tolvaptan) - treat hyponatremia, heart failure" ;
    ns1:primary_action "↑ Water Retention (V2 receptors → aquaporin-2 insertion) + Vasoconstriction (V1 receptors)" ;
    ns1:timescale "Minutes to hours" ;
    ns1:trigger "↑ Plasma osmolality (detected by hypothalamic osmoreceptors) OR ↓ Blood volume (detected by atrial stretch receptors)" .

<m0:blood_pressure_control:CardiacOutput> a owl:NamedIndividual ;
    rdfs:label "Cardiac Output & Volemia" ;
    rdfs:comment "Downstream hemodynamic parameters controlled by effectors 1-4. Cardiac Output (CO) = Heart Rate × Stroke Volume. Blood volume (volemia) determines venous return and preload (Starling mechanism). MAP = CO × Total Peripheral Resistance." ;
    ns1:blood_pressure_equation "MAP = CO × TPR (Mean Arterial Pressure = Cardiac Output × Total Peripheral Resistance)" ;
    ns1:clinical_measurement "Blood volume: Indicator dilution techniques, estimated from hematocrit",
        "Cardiac Output: Echocardiography (Doppler), thermodilution (Swan-Ganz catheter)",
        "Stroke Volume: Echocardiography (EDV - ESV)" ;
    ns1:controlled_by "Heart Rate: Sympathetic (↑ via β1) + Parasympathetic (↓ via muscarinic M2)",
        "Stroke Volume: Preload (volemia via Starling curve) + Contractility (sympathetic β1) + Afterload (TPR)",
        "Volemia: RAAS (↑), ADH (↑), ANP (↓), Renal excretion" ;
    ns1:effector_type "Hemodynamic parameter (downstream controlled variable)" ;
    ns1:formula "CO = HR × SV (Heart Rate × Stroke Volume)" ;
    ns1:m2_metaconcepts "m2:Dynamics (D⊗F) - Temporal evolution of cardiac output",
        "m2:Flow (F) - Blood flow (5 L/min in resting human)",
        "m2:State (I) - Hemodynamic state (CO, SV, HR as state variables)" ;
    ns1:starling_mechanism "↑ Venous return → ↑ End-diastolic volume (preload) → ↑ Stroke Volume (within physiological limits)" .

<m0:blood_pressure_control:NatriureticPeptides> a owl:NamedIndividual ;
    rdfs:label "Natriuretic Peptides (ANP, BNP)" ;
    rdfs:comment "Counter-regulatory hormones secreted by heart in response to volume/pressure overload. ANP (atrial natriuretic peptide) from atria, BNP (brain natriuretic peptide) from ventricles. Action: ↑ Sodium/water excretion + vasodilation → ↓ BP." ;
    ns1:effector_type "Hormonal counter-regulation" ;
    ns1:m2_metaconcepts "m2:Balance (A⊗S⊗F) - Counter-balances RAAS/Sympathetic vasoconstriction",
        "m2:Feedback (A⊗I⊗D) - Negative feedback (↑Volume → ↑ANP → ↓Volume)",
        "m2:Homeostasis (A⊗S⊗F) - Maintains fluid/pressure homeostasis" ;
    ns1:mechanism "ANP/BNP bind NPR-A receptors (kidney, vessels)",
        "Atrial/ventricular myocytes sense stretch → Secrete ANP/BNP",
        "Kidney: ↑ GFR + ↓ Sodium reabsorption (inhibit aldosterone) → ↑ Natriuresis/diuresis",
        "Net effect: ↓ Blood volume + ↓ TPR → ↓ BP",
        "Vessels: Vasodilation (via cGMP pathway) → ↓ TPR" ;
    ns1:pathology "Resistance in heart failure (blunted natriuretic response despite high ANP/BNP levels)" ;
    ns1:pharmacological_targets "Neprilysin inhibitors (e.g., sacubitril) - prevent ANP/BNP degradation, used in heart failure" ;
    ns1:primary_action "↑ Na/Water Excretion (kidney) + Vasodilation → ↓ Blood Pressure" ;
    ns1:timescale "Hours" ;
    ns1:trigger "↑ Atrial/ventricular stretch (volume overload or pressure overload)" .

<m0:blood_pressure_control:RAAS> a owl:NamedIndividual ;
    rdfs:label "Renin-Angiotensin-Aldosterone System (RAAS)" ;
    rdfs:comment "Hormonal cascade controlling volemia and vasoconstriction. Initiated by renin secretion from juxtaglomerular cells in response to decreased renal perfusion. Cascade: Renin → Angiotensinogen → Ang I → ACE → Ang II → Aldosterone." ;
    ns1:cascade_steps "ACE (lung endothelium) cleaves Ang I → Angiotensin II",
        "Aldosterone → ↑ Na reabsorption (distal tubule) → ↑ H2O retention → ↑ Volemia",
        "Ang II stimulates aldosterone secretion (adrenal cortex)",
        "Ang II → Vasoconstriction (AT1 receptors on smooth muscle)",
        "Renin (kidney) cleaves angiotensinogen → Angiotensin I" ;
    ns1:effector_type "Hormonal cascade" ;
    ns1:m2_metaconcepts "m2:Cascade (S⊗I⊗D) - Sequential enzymatic amplification",
        "m2:Regulation (A⊗S⊗F) - Hormonal control mechanism",
        "m2:Signal (I⊗F) - Hormonal information carrier" ;
    ns1:pathology "Hyperactivation in renovascular hypertension (renal artery stenosis), heart failure, cirrhosis" ;
    ns1:pharmacological_targets "ACE inhibitors (e.g., enalapril) - block Ang I → Ang II",
        "AT1 receptor blockers (e.g., losartan) - block Ang II binding",
        "Aldosterone antagonists (e.g., spironolactone) - block mineralocorticoid receptor",
        "Renin inhibitors (e.g., aliskiren) - block angiotensinogen cleavage" ;
    ns1:primary_action "↑ Volemia (aldosterone → Na/H2O retention) + ↑ Vasoconstriction (Ang II)" ;
    ns1:timescale "Minutes to hours" ;
    ns1:trigger "↓ Renal perfusion pressure (sensed by juxtaglomerular apparatus)" .

<m0:blood_pressure_control:Sympathetic> a owl:NamedIndividual ;
    rdfs:label "Sympathetic Nervous System" ;
    rdfs:comment "Rapid neural reflex controlling heart rate and vascular tone. Baroreceptor arc: Aortic/carotid baroreceptors → Vasomotor center (medulla) → Sympathetic efferents → Norepinephrine release." ;
    ns1:effector_type "Neural reflex" ;
    ns1:m2_metaconcepts "m2:Dynamics (D⊗F) - Fastest effector (seconds timescale)",
        "m2:Feedback (A⊗I⊗D) - Negative feedback loop (↑BP → ↓Sympathetic)",
        "m2:Threshold (A⊗I) - Baroreceptor firing threshold (~60-180 mmHg)" ;
    ns1:pathology "Overactivation in heart failure (compensatory response becomes maladaptive)" ;
    ns1:pharmacological_targets "Alpha-blockers (e.g., doxazosin) - block α1 receptors",
        "Beta-blockers (e.g., metoprolol) - block β1 receptors",
        "Centrally-acting agents (e.g., clonidine) - reduce sympathetic outflow from brainstem" ;
    ns1:primary_action "↑ Heart Rate (β1-adrenergic) + ↑ Vasoconstriction (α1-adrenergic)" ;
    ns1:reflex_arc "Baroreceptors (aortic arch, carotid sinus) sense ↓ BP → ↓ firing rate",
        "Sympathetic efferents → Norepinephrine release at heart and vessels",
        "Vasomotor center → ↑ Sympathetic outflow (RVLM activation)",
        "α1 receptors (vessels) → Vasoconstriction → ↑ Total Peripheral Resistance",
        "β1 receptors (heart) → ↑ HR + ↑ Contractility → ↑ Cardiac Output",
        "↓ Afferent signal to vasomotor center (NTS in medulla)" ;
    ns1:timescale "Seconds" ;
    ns1:trigger "↓ Arterial pressure detected by baroreceptors" .

